Diadez M2,5 L2,5 Disinfectant
Composition:
% 21 Citricacidmonohydrate, % 2,5 lacticacid, % 2,5 malicacid, adjuvants.
MicrobiologicalEffect:
DIADEZ M2,5 L2,5 has bactericidal (including Gram positive and negative bacteria, methicillin resistant bacteria, Camphylo bacteria and Mycobacterium), fungicidal (includingyeastandmolds) andvirucidal(including HBV, HCV, HIV, Polio, Papova, Adeno, Rota, VaccinaandPorvoviruses) effectswhenused as describedabove.
To be use daccordingmachineinstructions at elevatedtemperaturesonly.
Packaging
5L HDPE drums. Package: 4X5L
DIADEZ M2,5 L2,5 Disinfectant for FRESENIUS Hemodialysis Machines
Composition:
% 21 Citric acid monohydrate, % 2,5 lactic acid, % 2,5 malic acid, adjuvants.
Microbiological Effect:
DIADEZ M2,5 L2,5 has bactericidal (including Gram positive and negative bacteria, methicillin resistant bacteria, Camphylobacteria and Mycobacterium), fungicidal ( including yeast and molds) and virucidal (including HBV, HCV, HIV, Polio, Papova, Adeno, Rota, Vaccina and Porvo viruses) effects when used as described above.
To be used according machine instructions at elevated temperatures only.
Packaging
5L HDPE drums. Package: 4X5L
| PRODUCT | FOR 1 PCS 80*120 cm EURO PALLET | GROSS WEIGHT |
| 5 LiterDisinfectant | 120 PCS | 756 Kg |
| MANNER OF DELIVERY | QUANTITY OF PALLET CONTAINED |
| 40 Foot Container | 23 Pallet (80*120 EURO) |
| 20Foot Container | 11Pallet(80*120 EURO) |
| Standart Truck | 30Pallet(80*120 EURO) |
Blog
Farmasol joins Pollet Medical Group
January 7, 2025 – Farmasol, manufacturer of disposable products for dialysis, becomes part of Pollet Medical Group. The Turkish company counts 250 people and 2 production sites in Kayseri, Turkey. Pollet Medical Group is a Belgian group who operates in three domains: dialysis, plasmapheresis and sterilisation. PMG and Farmasol are both 100% family-owned businesses.
Farmasol takes a sustainable decision for green manufacturing
Green news! Farmasol is proud to announce groundbreaking decision for sustainability and renewable energy – the installation of a cutting-edge 1.7 MW solar power plant at the field in Nevsehir region. Over the next 25 years, this revolutionary solar power plant is projected to generate whole energy consumption of main manufacturing plant of Farmasol with an impressive approx. 60 million kWh of clean, renewable energy.